Offerings // Quoin Pharmaceuticals Ltd.

QNRX offering history

Every offering-related filing in Quoin Pharmaceuticals Ltd.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 578 filings back to Apr 8, 2016.

Last executed offering

Aug 28, 2026

8-K — priced deal (shares or notes)

Last registration (announced)

Oct 28, 2026

S-3 — capacity, not a sale

Executed, last 12 months

424B pricings + 8-K 3.02 sales

Registered, last 12 months

S-1/S-3/F-series registrations

Date	Filing		What it means
Oct 28, 2026	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Sep 25, 2026	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Sep 25, 2026	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Sep 18, 2026	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Aug 28, 2026	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jun 2, 2026	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Dec 5, 2025	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Dec 4, 2025	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Nov 7, 2025	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Oct 15, 2025	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Apr 3, 2025	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Dec 23, 2024	424B4 →	EXECUTED	Final prospectus — offering priced (typical for IPOs and marketed share deals)
Dec 20, 2024	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Dec 18, 2024	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Dec 11, 2024	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Dec 11, 2024	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet
Nov 8, 2024	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Aug 12, 2024	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
May 10, 2024	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
May 8, 2024	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Apr 3, 2024	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Mar 8, 2024	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Mar 8, 2024	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Mar 6, 2024	424B4 →	EXECUTED	Final prospectus — offering priced (typical for IPOs and marketed share deals)
Mar 4, 2024	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Feb 14, 2024	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Feb 13, 2024	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Feb 12, 2024	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet
Jan 31, 2024	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Jan 30, 2024	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Dec 18, 2023	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Nov 9, 2023	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Nov 7, 2023	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Nov 1, 2023	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Sep 14, 2023	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Aug 3, 2023	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Jul 18, 2023	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Jun 28, 2023	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
May 12, 2023	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
May 9, 2023	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital

QNRX offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full QNRX workspace →

QNRX offering FAQ

When did QNRX last execute an offering?

Per SEC filings, Quoin Pharmaceuticals Ltd.'s most recent priced offering document is a 8-K filed 2026-08-28. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did QNRX last announce or register an offering?

The most recent registration is a S-3 filed 2026-10-28. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.

Free to use. No account, no card.